Literature DB >> 11273068

Risk of clinical pelvic inflammatory disease attributable to an intrauterine device.

J D Shelton.   

Abstract

Use of the intrauterine device (IUD) is avoided because of perceived risk of pelvic inflammatory disease (PID) associated with sexually transmitted Infections (STI). Calculation of the risk of clinical pelvic inflammatory disease showed that the estimated risk was low (0.15%), even with a high STI prevalence. This estimated risk argues for making IUDs more available.

Mesh:

Year:  2001        PMID: 11273068     DOI: 10.1016/S0140-6736(00)04012-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  How safe is emergency contraception?

Authors:  Abigail Norris Turner; Charlotte Ellertson
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Positive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users.

Authors:  Natalia E Birgisson; Qiuhong Zhao; Gina M Secura; Tessa Madden; Jeffrey F Peipert
Journal:  J Womens Health (Larchmt)       Date:  2015-04-02       Impact factor: 2.681

Review 3.  [The family doctor facing IUD insertion].

Authors:  L Arribas-Mir; A Ortega Del Moral; M Jódar-Reyes
Journal:  Aten Primaria       Date:  2005-12       Impact factor: 1.137

4.  Preventing pregnancy: a fresh look at the IUD.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

5.  Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial.

Authors:  Othman Kakaire; Josaphat Kayogoza Byamugisha; Nazarius Mbona Tumwesigye; Kristina Gemzell-Danielsson
Journal:  Hum Reprod       Date:  2015-05-15       Impact factor: 6.918

Review 6.  Provider and lay perspectives on intra-uterine contraception: a global review.

Authors:  Marina A S Daniele; John Cleland; Lenka Benova; Moazzam Ali
Journal:  Reprod Health       Date:  2017-09-26       Impact factor: 3.223

7.  Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS.

Authors:  Paula H Bednarek; Jeffrey T Jensen
Journal:  Int J Womens Health       Date:  2010-08-09

Review 8.  Intrauterine devices & infection: review of the literature.

Authors:  David Hubacher
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

9.  The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.

Authors:  Megan N Beatty; Paul D Blumenthal
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

10.  Intrauterine device quo vadis? Why intrauterine device use should be revisited particularly in nulliparous women?

Authors:  Dirk Wildemeersch; Norman Goldstuck; Thomas Hasskamp; Sohela Jandi; Ansgar Pett
Journal:  Open Access J Contracept       Date:  2015-01-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.